Hu Shanshan, Guo Junjing, Wang Binbin, Wang Jing, Zhou Zhou, Zhou Guangkai, Ding Xuchen, Ma Xu, Qi Yanhua
Department of Ophthalmology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
Mol Vis. 2011 Feb 9;17:436-42.
The purpose of this study was to identify the mutation(s) or deletion(s) of the forkhead box protein L2 (FOXL2) gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES).
Genomic DNA extracted from peripheral blood was collected from two Chinese families and from one sporadic case. PCR direct sequencing and quantitative real-time PCR-based copy number screening for the whole exon of FOXL2 were performed.
Direct sequencing revealed an indel mutation c.50C→TA in the sporadic case which resulted in a frameshift generating 78 novel amino acids and terminating prematurely at codon 95. Deletions in the FOXL2 gene were confirmed by quantitative real-time PCR (q-real-time PCR) in two families in which intragenic mutations were excluded by direct sequencing. These changes containing deletions and a de novo mutation were not detected either in the non-carrier relatives or in 100 normal controls.
This study identified two deletions and a de novo mutation in the FOXL2 gene in Chinese BPES patients. This is the first study to report FOXL2 gene deletions detected by q-real-time PCR in this ethnic group. This technique enriches the diagnostic methods of molecular genetics in BPES patients. The de novo mutation expands the mutation spectrum of FOXL2.
本研究旨在鉴定中国睑裂狭小-上睑下垂-内眦赘皮综合征(BPES)患者中叉头框蛋白L2(FOXL2)基因的突变或缺失情况。
收集了两个中国家系和一例散发病例的外周血基因组DNA。对FOXL2基因的整个外显子进行了PCR直接测序和基于定量实时PCR的拷贝数筛选。
直接测序显示散发病例中存在一个插入缺失突变c.50C→TA,该突变导致移码,产生78个新氨基酸,并在第95密码子处提前终止。通过定量实时PCR(q-实时PCR)在两个家系中证实了FOXL2基因的缺失,这两个家系通过直接测序排除了基因内突变。在非携带者亲属或100名正常对照中均未检测到这些包含缺失和一个新发突变的变化。
本研究在中国BPES患者中鉴定出FOXL2基因的两个缺失和一个新发突变。这是首次报道在该族群中通过q-实时PCR检测到FOXL2基因缺失的研究。该技术丰富了BPES患者分子遗传学的诊断方法。新发突变扩展了FOXL2的突变谱。